tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
NGM Biopharmaceuticals's activity chart (see below) currently has 68 price targets and 69 ratings on display.
Analysts average stock forecasts to be materialized ratio is 53.73% with an average time for these price targets to be met of 167 days.
Most recent stock forecast was given by STEVEN SEEDHOUSE from RAYMOND JAMES on 12-Mar-2024. First documented stock forecast 29-Apr-2019.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 07-Apr-2020
$6
2 years 6 months 17 days ago
(12-Mar-2024)
2/10 (20%)
$0.64 (11.94%)
154
Buy Since 29-Apr-2019
$1.55
$0.01 (0.65%)
2 years 7 months 1 days ago
(28-Feb-2024)
3/3 (100%)
$0.02 (1.31%)
302
Buy Since 30-Mar-2023
$1.55
$0.01 (0.65%)
2 years 7 months 1 days ago
(28-Feb-2024)
1/2 (50%)
$0.02 (1.31%)
16
Buy Since 27-Feb-2024
$1.55
$0.01 (0.65%)
2 years 7 months 2 days ago
(27-Feb-2024)
1/1 (100%)
$-0.08 (-4.91%)
1
Buy Since 17-Oct-2019
$3.5
$1.96 (127.27%)
$7
2 years 10 months 7 days ago
(22-Nov-2023)
3/9 (33.33%)
$2.79 (392.96%)
262
What is NGM (NGM Biopharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on NGM (NGM Biopharmaceuticals)?
Which analyst has the most public recommendations on NGM (NGM Biopharmaceuticals)?
Which analyst is the currently most bullish on NGM (NGM Biopharmaceuticals)?
Which analyst is the currently most reserved on NGM (NGM Biopharmaceuticals)?
